Cetera Advisor Networks’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,674
Closed -$370K 2106
2021
Q4
$370K Sell
3,674
-1,512
-29% -$133K ﹤0.01% 1478
2021
Q3
$466K Buy
5,186
+395
+8% +$35.9K 0.01% 1265
2021
Q2
$442K Buy
+4,791
New +$383K 0.01% 1250
2020
Q3
Sell
-100
Closed -$2K 1835
2020
Q2
$2K Buy
+100
New +$1.53K ﹤0.01% 3228

Other funds holding FLGT

Cetera Advisor Networks's FLGT Position: Q1 2022 in Review

Cetera Advisor Networks sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 3,674 shares — an estimated $370K sold.

Cetera Advisor Networks first reported a position in FLGT in Q2 2020 and held it in 4 quarters. The position peaked at $466K in Q3 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Cetera Advisor Networks reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 3,674 Fulgent Genetics shares in Q1 2022, an estimated $370K.
  • Cetera Advisor Networks first reported a position in Fulgent Genetics in Q2 2020 and held it in 4 quarters.
  • Cetera Advisor Networks's Fulgent Genetics position peaked at $466K in Q3 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.